Published in Oncogene on October 13, 2008
New and emerging HDAC inhibitors for cancer treatment. J Clin Invest (2014) 3.35
Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal (2010) 2.44
HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol (2012) 1.67
Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4). Proc Natl Acad Sci U S A (2012) 1.19
Autophagic and apoptotic effects of HDAC inhibitors on cancer cells. J Biomed Biotechnol (2011) 1.10
Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. Oncogene (2011) 1.10
Vitamin D and the epigenome. Front Physiol (2014) 1.04
Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment. Cancer Res (2012) 1.04
A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. J Biol Chem (2010) 1.02
Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. Nucleic Acids Res (2010) 1.00
Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer. J Hematol Oncol (2011) 0.94
HDAC4: mechanism of regulation and biological functions. Epigenomics (2014) 0.92
HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells. Oncotarget (2014) 0.90
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma. Epigenetics (2014) 0.89
C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21(waf1/cip1) promoter. Oncogene (2010) 0.89
miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis. Oncotarget (2015) 0.89
MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality. Mol Cancer (2011) 0.88
The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2. PLoS One (2013) 0.88
HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. Cell Res (2011) 0.88
HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death Differ (2012) 0.87
Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease. J Biol Chem (2014) 0.87
Sp1 transcription factor and GATA1 cis-acting elements modulate testis-specific expression of mouse cyclin A1. PLoS One (2012) 0.87
Targeting histone deacetylases in pancreatic ductal adenocarcinoma. J Cell Mol Med (2009) 0.86
Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer. J Histochem Cytochem (2013) 0.86
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation. Mol Cell Biol (2013) 0.85
Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression. PLoS One (2014) 0.84
HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1. Cell Mol Immunol (2010) 0.82
Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells. BMC Complement Altern Med (2014) 0.81
The multi zinc-finger protein Trps1 acts as a regulator of histone deacetylation during mitosis. Cell Cycle (2013) 0.81
Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1. Cell Cycle (2014) 0.81
The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation. Int J Mol Sci (2015) 0.80
Cloning and characterization of the human USP22 gene promoter. PLoS One (2012) 0.79
AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition. Oncotarget (2016) 0.79
Pathologic Regulation of Collagen I by an Aberrant Protein Phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 Signal Axis in Idiopathic Pulmonary Fibrosis Fibroblasts. Am J Respir Cell Mol Biol (2015) 0.78
Methoxyacetic acid suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. Am J Clin Exp Urol (2014) 0.77
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer. J Cancer Res Clin Oncol (2015) 0.76
Histone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphoma. Sci Rep (2016) 0.75
miR-378a-3p promotes differentiation and inhibits proliferation of myoblasts by targeting HDAC4 in skeletal muscle development. RNA Biol (2016) 0.75
Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. Aging (Albany NY) (2016) 0.75
Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition. Oncogene (2017) 0.75
Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science (2001) 6.79
Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J (1996) 5.10
The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr (1996) 4.62
A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev (2000) 4.23
Galectins: a family of animal beta-galactoside-binding lectins. Cell (1994) 3.99
Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene (2007) 3.85
The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J (2001) 3.80
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A (1998) 3.62
Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol (2005) 3.51
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
Characterization of a human RPD3 ortholog, HDAC3. Proc Natl Acad Sci U S A (1998) 3.05
Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature (1998) 3.02
BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev (2000) 2.83
A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J Biol Chem (1999) 2.82
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest (1998) 2.65
Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins (2004) 2.51
The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A (2000) 2.42
Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet (2005) 2.35
Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol (2000) 2.30
Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev (1997) 2.25
Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J Biol Chem (2001) 2.24
Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J Virol (1998) 2.23
A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc Natl Acad Sci U S A (1996) 2.06
Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science (1997) 1.97
Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J Biol Chem (2001) 1.97
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry (1989) 1.80
Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer (1996) 1.76
Reduced mobility of the alternate splicing factor (ASF) through the nucleoplasm and steady state speckle compartments. J Cell Biol (2000) 1.76
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer (1996) 1.75
Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res (2000) 1.69
Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J Virol (1997) 1.56
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. Cancer Res (2001) 1.56
Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol (1992) 1.52
Snoring and nocturnal oxygen desaturations in an Italian middle-aged male population. Epidemiologic study with an ambulatory device. Chest (1994) 1.50
Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. Hum Pathol (1995) 1.45
Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol (1995) 1.43
Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol (1985) 1.42
Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol (1991) 1.39
Formation of the 67-kDa laminin receptor by acylation of the precursor. J Cell Biochem (1998) 1.34
The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. Mol Biol Evol (1998) 1.33
The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol (1994) 1.33
Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events. J Cell Biol (1990) 1.32
Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J Immunol (1998) 1.31
Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene (1995) 1.29
Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J Virol (1998) 1.29
A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol (1994) 1.26
Integrative and free Spiroplasma citri oriC plasmids: expression of the Spiroplasma phoeniceum spiralin in Spiroplasma citri. J Bacteriol (1995) 1.25
Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol (1997) 1.25
Correlation between human papillomavirus (HPV) type and histology of warts. J Invest Dermatol (1982) 1.25
Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol (1985) 1.24
Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res (1994) 1.24
Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology (2004) 1.22
SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp Quant Biol (2011) 1.22
Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res (2001) 1.21
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. Oncogene (2012) 1.21
Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine (2006) 1.20
The emerging role of class II histone deacetylases. Biochem Cell Biol (2001) 1.19
HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochem Biophys Res Commun (1999) 1.17
Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res (1994) 1.16
Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res (1996) 1.16
Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J Biol Chem (1994) 1.16
Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells. Eur J Histochem (2004) 1.14
Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol (1996) 1.13
Co-regulation and physical association of the 67-kDa monomeric laminin receptor and the alpha6beta4 integrin. J Biol Chem (1997) 1.13
Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol (2001) 1.13
New insights into the metastasis-associated 67 kD laminin receptor. J Cell Biochem (1997) 1.11
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood (1999) 1.09
Characterization of human papillomavirus 3 in warts of a renal allograft patient. J Invest Dermatol (1979) 1.08
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol (1996) 1.08
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood (1998) 1.08
Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer (2000) 1.08
An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc Natl Acad Sci U S A (2001) 1.07
Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst (1998) 1.07
Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis (1999) 1.06
Structural Organization of the WD repeat protein-encoding gene HIRA in the DiGeorge syndrome critical region of human chromosome 22. Genome Res (1996) 1.03
Detection of HOXA1 expression in human breast cancer. Biochem Biophys Res Commun (1996) 1.03
Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Res (1992) 1.02
AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res (1994) 1.02
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res (2001) 1.02
Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer (1994) 1.02
Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol (1997) 1.01
Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. Am J Pathol (1997) 1.00
The restricted nature of HIV-1 tropism for cultured neural cells. Virology (1992) 1.00
Expression and modulation of homeobox genes from cluster B in endothelial cells. Lab Invest (1998) 0.99
Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer (1996) 0.99
Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst (1991) 0.98
Retinoic acid induces three newly cloned HOXA1 transcripts in MCF7 breast cancer cells. Biochem Biophys Res Commun (1995) 0.97
67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Clin Cancer Res (1997) 0.96
Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat (2006) 0.95
Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem Biophys Res Commun (1995) 0.95
The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. J Virol (1991) 0.95
Isolation from a multigene family of the active human gene of the metastasis-associated multifunctional protein 37LRP/p40 at chromosome 3p21.3. Oncogene (1996) 0.94
Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res (2000) 0.94
Dentin matrix protein 1 is expressed in human lung cancer. J Bone Miner Res (2003) 0.94